267 related articles for article (PubMed ID: 10573045)
1. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group.
Bates DW; Miller EB; Cullen DJ; Burdick L; Williams L; Laird N; Petersen LA; Small SD; Sweitzer BJ; Vander Vliet M; Leape LL
Arch Intern Med; 1999 Nov; 159(21):2553-60. PubMed ID: 10573045
[TBL] [Abstract][Full Text] [Related]
2. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.
Bates DW; Spell N; Cullen DJ; Burdick E; Laird N; Petersen LA; Small SD; Sweitzer BJ; Leape LL
JAMA; 1997 Jan 22-29; 277(4):307-11. PubMed ID: 9002493
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for hospital admissions associated with adverse drug events.
Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
[TBL] [Abstract][Full Text] [Related]
4. Hospital admissions caused by adverse drug events: an Australian prospective study.
Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
[TBL] [Abstract][Full Text] [Related]
5. Emergency department visits caused by adverse drug events: results of a French survey.
Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X; Lapostolle F; Borron SW; Adnet F;
Drug Saf; 2007; 30(1):81-8. PubMed ID: 17194173
[TBL] [Abstract][Full Text] [Related]
6. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug events caused by medication errors in medical inpatients.
Hardmeier B; Braunschweig S; Cavallaro M; Roos M; Pauli-Magnus C; Giger M; Meier PJ; Fattinger K
Swiss Med Wkly; 2004 Nov; 134(45-46):664-70. PubMed ID: 15611888
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.
Hug BL; Witkowski DJ; Sox CM; Keohane CA; Seger DL; Yoon C; Matheny ME; Bates DW
J Gen Intern Med; 2010 Jan; 25(1):31-8. PubMed ID: 19894081
[TBL] [Abstract][Full Text] [Related]
9. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.
Jha AK; Kuperman GJ; Teich JM; Leape L; Shea B; Rittenberg E; Burdick E; Seger DL; Vander Vliet M; Bates DW
J Am Med Inform Assoc; 1998; 5(3):305-14. PubMed ID: 9609500
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug events in hospitalized elderly.
Gray SL; Sager M; Lestico MR; Jalaluddin M
J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M59-63. PubMed ID: 9467435
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP
JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492
[TBL] [Abstract][Full Text] [Related]
12. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of MBDS in detection of adverse drug events].
Sánchez Muñoz LA; Castiella Herrero J; Sanjuán Portugal FJ; Naya Manchado J; Alfaro Alfaro MJ
An Med Interna; 2007 Mar; 24(3):113-9. PubMed ID: 17590131
[TBL] [Abstract][Full Text] [Related]
14. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.
Klopotowska JE; Wierenga PC; Stuijt CC; Arisz L; Dijkgraaf MG; Kuks PF; Asscheman H; de Rooij SE; Lie-A-Huen L; Smorenburg SM;
PLoS One; 2013; 8(8):e71045. PubMed ID: 23940688
[TBL] [Abstract][Full Text] [Related]
16. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database.
Sonawane KB; Cheng N; Hansen RA
J Manag Care Spec Pharm; 2018 Jul; 24(7):682-690. PubMed ID: 29952714
[TBL] [Abstract][Full Text] [Related]
17. Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study.
Sakuma M; Bates DW; Morimoto T
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1221-6. PubMed ID: 22887972
[TBL] [Abstract][Full Text] [Related]
18. Identifying hospital admissions due to adverse drug events using a computer-based monitor.
Jha AK; Kuperman GJ; Rittenberg E; Teich JM; Bates DW
Pharmacoepidemiol Drug Saf; 2001; 10(2):113-9. PubMed ID: 11499849
[TBL] [Abstract][Full Text] [Related]
19. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.
Hougland P; Xu W; Pickard S; Masheter C; Williams SD
Med Care; 2006 Jul; 44(7):629-36. PubMed ID: 16799357
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug events in surgical patients: an observational multicentre study.
de Boer M; Boeker EB; Ramrattan MA; Kiewiet JJ; Dijkgraaf MG; Boermeester MA; Lie-A-Huen L
Int J Clin Pharm; 2013 Oct; 35(5):744-52. PubMed ID: 23722455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
